Enlivex Therapeutics Ltd (ENLV) — Long-term Investment Intensity
Enlivex Therapeutics Ltd (ENLV) has a Long-term Investment Intensity of 0.0% as of December 2021. Long-term investments of ILA3.00K represent 0.0% of total assets of ILA95.15 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Enlivex Therapeutics Ltd (ENLV) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Enlivex Therapeutics Ltd Long-term Investment Intensity (2021–2021)
This chart shows how Enlivex Therapeutics Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the intensity stands at 0.0%, reflecting long-term investments of ILA3.00K against total assets of ILA95.15 Million ILA. Explore Enlivex Therapeutics Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Enlivex Therapeutics Ltd (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Enlivex Therapeutics Ltd from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ENLV market cap.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.0% | ILA3.00K | ILA95.15 Million | — |